{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:24:52Z","timestamp":1788909892879,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dr. Ferrer Biopharma","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-10211-8","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:13:18Z","timestamp":1732637598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studies"],"prefix":"10.1186","volume":"24","author":[{"given":"Fernando","family":"Valerio-Pascua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Baires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupamjeet Kaur","family":"Sekhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari L.","family":"Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela Jackeline","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed A. A.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmanjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Abraham","family":"Cortes-Bandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Madril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Radwanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita S.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Sierra-Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck F.","family":"Rahaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"10211_CR1","doi-asserted-by":"crossref","unstructured":"Rubin R. As their numbers grow, COVID-19 long haulers stump experts. JAMA. 2020;324(14):1381. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2771111","DOI":"10.1001\/jama.2020.17709"},{"key":"10211_CR2","doi-asserted-by":"crossref","unstructured":"Carf\u00ec A, Bernabei R, Landi F, Gemelli Against, COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2768351","DOI":"10.1001\/jama.2020.12603"},{"key":"10211_CR3","unstructured":"Clinical Services and Systems, Diseases C, Technical Advisory Group on SARS-CoV-2 Virus Evolution. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization; 2021. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 27 Sep 2023."},{"issue":"11","key":"10211_CR4","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","volume":"43","author":"B Raman","year":"2022","unstructured":"Raman B, Bluemke DA, L\u00fcscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157\u201372. https:\/\/doi.org\/10.1093\/eurheartj\/ehac031.","journal-title":"Eur Heart J"},{"key":"10211_CR5","doi-asserted-by":"crossref","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133\u2009\u2013\u200946. https:\/\/www.nature.com\/articles\/s41579-022-00846-2. Accessed 27 Sep 2023.","DOI":"10.1038\/s41579-022-00846-2"},{"issue":"10350","key":"10211_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","volume":"400","author":"AV Ballering","year":"2022","unstructured":"Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(22)01214-4.","journal-title":"Lancet"},{"issue":"8","key":"10211_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333. https:\/\/doi.org\/10.1056\/NEJMoa2001017.","journal-title":"N Engl J Med"},{"key":"10211_CR8","doi-asserted-by":"crossref","unstructured":"European Centre for Disease Prevention and Control. Cluster of pneumonia cases caused by a novel coronavirus, Wuhan, China; \u2013 17 January 2020. Volume ECDC. Stockholm; 2020.","DOI":"10.17265\/1548-6648\/2020.01.004"},{"issue":"9","key":"10211_CR9","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593\u2013607. https:\/\/doi.org\/10.1093\/infdis\/jiac136.","journal-title":"J Infect Dis"},{"key":"10211_CR10","doi-asserted-by":"publisher","unstructured":"Westover JB, Ferrer G, Vazquez H, Bethencourt-Mirael A, Go CC. In vitro virucidal effect of intranasally delivered chlorpheniramine maleate compound against severe acute respiratory syndrome coronavirus 2. Cureus. 2020;12(9). https:\/\/doi.org\/10.7759\/cureus.10501.","DOI":"10.7759\/cureus.10501"},{"key":"10211_CR11","doi-asserted-by":"crossref","unstructured":"Valerio-Pascua F, Mejia EJP, Tesch ML, Godoy J, Fuentes CL, Erazo GB et al. Chlorpheniramine intranasal spray to accelerate COVID-19 clinical recovery in an outpatient setting: The ACCROS trials. Research Square. 2022. https:\/\/www.researchsquare.com\/article\/rs-2167465\/v1. Accessed 29 Sep 2023.","DOI":"10.21203\/rs.3.rs-2167465\/v1"},{"issue":"7","key":"10211_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cmi.2022.02.018","volume":"28","author":"D Yelin","year":"2022","unstructured":"Yelin D, Moschopoulos CD, Margalit I, Gkrania-Klotsas E, Landi F, Stahl JP, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):955\u201372. https:\/\/doi.org\/10.1016\/j.cmi.2022.02.018.","journal-title":"Clin Microbiol Infect"},{"key":"10211_CR13","doi-asserted-by":"crossref","unstructured":"Greenhalgh T, Knight M, A\u2019Court C, Buxton M, Husain L. Management of post-acute COVID-19 in primary care. BMJ. 2020;370 https:\/\/www.bmj.com\/content\/370\/bmj.m3026. Accessed 29 Sep 2023.","DOI":"10.1136\/bmj.m3026"},{"key":"10211_CR14","doi-asserted-by":"publisher","unstructured":"Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: an overview and approach to classification. Open Forum Infect Dis. 2020;7(12). https:\/\/doi.org\/10.1093\/ofid\/ofaa509.","DOI":"10.1093\/ofid\/ofaa509"},{"key":"10211_CR15","unstructured":"Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329(22):1934. https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2805540. Accessed 31 Oct 2023."},{"key":"10211_CR16","doi-asserted-by":"publisher","first-page":"102492","DOI":"10.1016\/j.tmaid.2022.102492","volume":"51","author":"CA Alvarez-Moreno","year":"2023","unstructured":"Alvarez-Moreno CA, Pineda J, Bare\u00f1o A, Espitia R, Rengifo P. Long COVID-19 in Latin America: low prevalence, high resilience or low surveillance and difficulties accessing health care? Travel Med Infect Dis. 2023;51:102492. https:\/\/doi.org\/10.1016\/j.tmaid.2022.102492.","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"10211_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-30836-0","volume":"13","author":"EJ Thompson","year":"2022","unstructured":"Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):1\u201311. https:\/\/doi.org\/10.1038\/s41467-022-30836-0.","journal-title":"Nat Commun"},{"issue":"8","key":"10211_CR18","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","volume":"28","author":"A Subramanian","year":"2022","unstructured":"Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706\u201314. https:\/\/doi.org\/10.1038\/s41591-022-01909-w.","journal-title":"Nat Med"},{"issue":"9","key":"10211_CR19","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/cea.14391","volume":"53","author":"D Wolff","year":"2023","unstructured":"Wolff D, Drewitz KP, Ulrich A, et al. Allergic diseases as risk factors for long-COVID symptoms: systematic review of prospective cohort studies. Clin Exp Allergy. 2023;53(9):961\u201375. https:\/\/doi.org\/10.1111\/cea.14391.","journal-title":"Clin Exp Allergy"},{"issue":"19","key":"10211_CR20","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.2021.5612","volume":"325","author":"S Havervall","year":"2021","unstructured":"Havervall S, Rosell A, Phillipson M, Mangsbo SM, Nilsson P, Hober S, et al. Symptoms and functional impairment assessed 8 months after mild COVID-19 among healthcare workers. JAMA. 2021;325(19):2015. https:\/\/doi.org\/10.1001\/jama.2021.5612.","journal-title":"JAMA"},{"issue":"1","key":"10211_CR21","doi-asserted-by":"publisher","first-page":"36995","DOI":"10.1038\/s41598-023-36995-4","volume":"13","author":"Y Kim","year":"2023","unstructured":"Kim Y, Bae S, Chang H-H, Kim S-W. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci Rep. 2023;13(1):36995\u20134. https:\/\/doi.org\/10.1038\/s41598-023-36995-4.","journal-title":"Sci Rep"},{"issue":"9","key":"10211_CR22","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","volume":"29","author":"B Bowe","year":"2023","unstructured":"Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat Med. 2023;29(9):2347\u201357. https:\/\/doi.org\/10.1038\/s41591-023-02521-2.","journal-title":"Nat Med"},{"key":"10211_CR23","doi-asserted-by":"publisher","unstructured":"Tan J, Anderson DE, Rathore APS, O\u2019Neill A, Mantri CK, Saron WAA et al. Signatures of mast cell activation are associated with severe COVID-19. bioRxiv. 2021. https:\/\/doi.org\/10.1101\/2021.05.31.21255594","DOI":"10.1101\/2021.05.31.21255594"},{"key":"10211_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.28.554806","author":"YAMM Elshaier","year":"2023","unstructured":"Elshaier YAMM, Mostafa A, Valerio-Pascua F, Tesch ML, Costin JM, Rahaghi FF. Chlorpheniramine maleate displays multiple modes of antiviral action against SARS-CoV-2: a mechanistic study. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.08.28.554806.","journal-title":"bioRxiv"},{"issue":"1","key":"10211_CR25","doi-asserted-by":"publisher","first-page":"e20980","DOI":"10.7759\/cureus.20980","volume":"14","author":"SD Black","year":"2022","unstructured":"Black SD. Molecular modeling and preliminary Clinical Data suggesting antiviral activity for chlorpheniramine (chlorphenamine) against COVID-19. Cureus. 2022;14(1):e20980. https:\/\/doi.org\/10.7759\/cureus.20980. PMID: 35154957; PMCID: PMC8820487.","journal-title":"Cureus"},{"issue":"2","key":"10211_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1691\/pharmazie.2021.2","volume":"76","author":"SA Kumar","year":"2021","unstructured":"Kumar SA, Cheng W. A hypothesis: bitter taste receptors as a therapeutic target for the clinical symptoms of SARS-CoV-2. Pharmazie. 2021;76(2):43\u201354. https:\/\/doi.org\/10.1691\/pharmazie.2021.2.","journal-title":"Pharmazie"},{"issue":"2","key":"10211_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2500\/105065898781390271","volume":"12","author":"S-Y Fang","year":"1998","unstructured":"Fang S-Y, Druce HM, Baraniuk JN. Anticholinergic properties of brompheniramine, chlorpheniramine, and atropine in human nasal mucosa in vitro. Am J Rhinol. 1998;12(2):131\u20134. https:\/\/doi.org\/10.2500\/105065898781390271.","journal-title":"Am J Rhinol"},{"issue":"1","key":"10211_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00011-020-01422-1","volume":"70","author":"M Ennis","year":"2021","unstructured":"Ennis M, Tiligada K. Histamine receptors and COVID-19. Inflamm Res. 2021;70(1):67\u201375. https:\/\/doi.org\/10.1007\/s00011-020-01422-1.","journal-title":"Inflamm Res"},{"key":"10211_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.35248\/2161-1459.21.10.275","volume":"10","author":"J Torres","year":"2021","unstructured":"Torres J, Go CC, Chohan F, Genesis Camacho L, Sanchez-Gonzalez MA, Ferrer G. Chlorpheniramine maleate nasal spray in COVID-19Patients: Case Series. J Clin Exp Pharmacol. 2021;10:275. https:\/\/doi.org\/10.35248\/2161-1459.21.10.275.","journal-title":"J Clin Exp Pharmacol"},{"key":"10211_CR30","doi-asserted-by":"publisher","unstructured":"Wang Y, Zhao D, Xiao W, Shi J, Chen W, Jia Q, et al. Paxlovid reduces the risk of long COVID in patients six months after hospital discharge. J Med Virol. 2023;95(8). https:\/\/doi.org\/10.1002\/jmv.29014.","DOI":"10.1002\/jmv.29014"},{"issue":"11","key":"10211_CR31","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.7326\/M23-1394","volume":"176","author":"GN Ioannou","year":"2023","unstructured":"Ioannou GN, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, et al. Effectiveness of nirmatrelvir-ritonavir against the development of post-COVID-19 conditions among U.S. veterans: a target trial emulation. Ann Intern Med. 2023;176(11):1486\u201397. https:\/\/doi.org\/10.7326\/M23-1394.","journal-title":"Ann Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10211-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-10211-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-10211-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T16:19:07Z","timestamp":1732637947000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-10211-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["10211"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-10211-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Ethics Committee of Investigation of Infectious and Zoonotic Disease at the Universidad Nacional Aut\u00f3noma de Honduras. Written informed consent was obtained from all participants prior to their involvement in the study. In cases where verbal consent was required (e.g., remote participation), this consent was documented and witnessed by study personnel. No waivers of consent were requested or provided by the ethics committee, and no minors were included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A-Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1348"}}